{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-098523","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2025-10-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.430356+00:00","generated_at":"2026-05-17T04:04:04.370064+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Ironwood Pharmaceuticals director Andrew Dreyfus resigns effective Nov 1, 2025","bullets":["Andrew Dreyfus resigned from the Board, effective November 1, 2025.","Resignation due to his appointment as President and CEO of NIHCM Foundation.","No disagreement with Ironwood's operations, policies, or practices.","Company expressed gratitude for his service on the Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-098523","json":"https://secwatch.observer/filing/0001104659-25-098523.json","markdown":"https://secwatch.observer/filing/0001104659-25-098523.md","text":"https://secwatch.observer/filing/0001104659-25-098523.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465925098523/0001104659-25-098523-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465925098523/tm2528244d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:04:04.370064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}